Business Description
Bionano Genomics Inc
NAICS : 334516
SIC : 3841
ISIN : US09075F3055
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.34 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -10.94 | |||||
Beneish M-Score | -3.12 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9 | |||||
3-Year EBITDA Growth Rate | -20.7 | |||||
3-Year EPS without NRI Growth Rate | -8.8 | |||||
3-Year FCF Growth Rate | -0.4 | |||||
3-Year Book Growth Rate | 4.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 60.41 | |||||
Future 3-5Y Total Revenue Growth Rate | 14.97 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -69.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.63 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.51 | |||||
Days Inventory | 339.49 | |||||
Days Sales Outstanding | 80.16 | |||||
Days Payable | 158.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34 | |||||
Shareholder Yield % | -219.92 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.97 | |||||
Operating Margin % | -282.07 | |||||
Net Margin % | -557.98 | |||||
FCF Margin % | -290.01 | |||||
ROE % | -172.09 | |||||
ROA % | -106.85 | |||||
ROIC % | -78.07 | |||||
ROC (Joel Greenblatt) % | -451.69 | |||||
ROCE % | -144.83 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.23 | |||||
PB Ratio | 0.37 | |||||
Price-to-Tangible-Book | 0.59 | |||||
EV-to-EBIT | -0.23 | |||||
EV-to-EBITDA | -0.24 | |||||
EV-to-Revenue | 1.23 | |||||
EV-to-Forward-Revenue | 0.74 | |||||
EV-to-FCF | -0.42 | |||||
Price-to-Net-Current-Asset-Value | 2.63 | |||||
Earnings Yield (Greenblatt) % | -434.78 | |||||
FCF Yield % | -293.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bionano Genomics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 33.848 | ||
EPS (TTM) (€) | -3.017 | ||
Beta | 0 | ||
Volatility % | 43.73 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 4.389 | ||
12-1 Month Momentum % | -69.6 | ||
52-Week Range (€) | 4.389 - 15.124 | ||
Shares Outstanding (Mil) | 38.84 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bionano Genomics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bionano Genomics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Bionano Genomics Inc Frequently Asked Questions
What is Bionano Genomics Inc(FRA:2Y30)'s stock price today?
When is next earnings date of Bionano Genomics Inc(FRA:2Y30)?
Does Bionano Genomics Inc(FRA:2Y30) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |